Advertisement

Reactions Weekly

, Volume 1722, Issue 1, pp 164–164 | Cite as

Golimumab

Inflammatory myopathy: case report
Case report
  • 18 Downloads

Reference

  1. Hirunagi T, et al. Anti-Mi-2 antibody-positive inflammatory myopathy during treatment with golimumab. Neurology and Clinical Neuroscience 6: 131-132, No. 5, Sep 2018. Available from: URL: http://doi.org/10.1111/ncn3.12202 -JapanCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations